This topic is a starting point of a broad discussion, and perhaps a place to share ideas or already made templates on how to structure Covid-19 vaccinations in openEHR. There are archetypes available in the international CKM, but might need tweeking or spesialization. It is anticipated that there wi…

Don’t think it matters really maybe start again here with a bit more scene-setting. e.g. openEHR COVID-19 Project and we can refer to the other conversation and pull through the artefacts.

I finally found time to work on the idea of specialising CLUSTER.medication to record vaccin information. I think it works pretty well. Only renamed some discriptions (some yet to be done). And added an element for ‘treated disease’. That could even make sense to be added to the parent archetype so …

Interesting. @Paulmiller and I did something a little different which was to add the Target disease and some other elements that are required for public health reporting and vaccine certification to a specialisation of the ACTION.medication archetype. This is the Vaccination record in the context …

Hi Ian, I generally agree. I do think it’s more about immunisation to an infectious agent (e.g. immunisation against SARS-CoV-2) instead of a disease (COVID-19). But either could work. If we’d go for the ‘target disease’ I think you could specialise the ‘clinical indication’ element in ACTION.medi…

Yes I also wondered about target disease vs. clinical indication but ‘target disease’ tends to be how the public health folks /WHO describe it and I suspect this may be more about reporting, so felt it better tp keep it separate from clinical indication. The Medication clusters were designed to…

'‘brand name (comirnaty)’ and ‘product name (flask of 3ml of pfizer covid vaccine, as a powder for injection)’ could both be handled as separate Medication Clusters how about nesting the comirnaty cluster in the product name cluster? I do feel it has value to create seperate elements for generic …

[image] ian.mcnicoll: target disease In the Immunisation summary archetype, we currently have ‘Infectious disease or agent’, which is the target [image] ian.mcnicoll: One other thing that we needed to extend was the total number of expected doses in the protocol, which is not in the orig…

[image] heather.leslie: We need to be able to clearly manage recording #1 of a course of ‘n’ vaccinations, plus manage the textual status for ‘Booster’ - see CR-363 in CKM. It’s not as simple as a count, but maybe needs to be SCT coded as ‘first’, ‘second’, ‘booster’. We possibly need to hand…

@ian.mcnicoll could you share the adl for this template that you shared? the link is no longer active. TIA

Covid-19 vaccination

Clinical

joostholslag (Joost Holslag) 4 December 2020 10:37 2

see also: SARS-CoV-2 immunisation
or should we stick to that forum?

Topic		Replies	Views
Swiss vaccination record in openEHR – best practices for modeling? Clinical	19	157	11 March 2026
SARS-CoV-2 immunisation Covid-19	7	1351	7 December 2020
Medication order - preparation details Ask IEB	19	670	18 December 2021
SpO2 scale 2 decision Clinical archetype	33	1045	19 November 2025
Sex Parameter for Clinical Use (SPCU) Clinical	21	1219	17 June 2025
New Oncology Archetypes Clinical archetype	39	3136	25 November 2021
How to use the "Symptom/sign screening questionnaire" archetype Clinical archetype , template	18	1333	6 September 2023
Pattern for modelling of scores (and PEWS) Clinical	27	2356	2 February 2021
openEHR COVID-19 Project Covid-19 covid-19	28	6918	24 April 2020
openEHR and FHIR UKCore openEHR.uk	27	1912	6 May 2024

Covid-19 vaccination

Related topics